Follow
Star
A star is a glowing, spherical astronomical object. Stars are held together by their own gravitational forces. The star closest to the Earth is the Sun.
OCT 07, 2021 | 8:00 AM
Date: October 7, 2021 Time: 8:00am (PDT), 11:00am (EDT) To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential. A...
SEP 29, 2021 | 7:30 AM
Nucleic acid testing is crucial for the prevention, diagnosis and treatment monitoring of many diseases in medicine. Over the last years, microRNAs (miRNAs), short non-coding RNAs, as biomar...
SEP 09, 2021 | 12:00 PM
Learning Objectives: 1. Understand the viral kinetics and impact on testing for patients with COVID-19. 2. Understand available testing options. 3. Be able to determine positive and negative...
SEP 08, 2021 | 9:00 AM
Date: September 8, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Implanted biomedical devices comprise a major component of modern medicine and are essential for many clinical applications ranging...
JUL 15, 2021 | 8:00 AM
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
JUN 03, 2021 | 12:00 PM
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
APR 14, 2021 | 6:00 AM
Two studies on the immunology of COVID-19 are included in this webinar: First, Eugenia Ong, PhD with the Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS) and...
NOV 19, 2020 | 9:00 AM
Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
NOV 12, 2020 | 12:00 AM
Point-of-care testing (POCT) is destined to play a much greater role in chronic disease diagnosis and management. Advanced POCT systems are being developed to deliver less costly and more ac...
OCT 07, 2020 | 12:00 AM
Activating mutations in PIK3CA are frequent in human breast cancer, and phosphoinositide 3-kinase alpha (PI3Kα) inhibitors have been approved for therapy. To characterize determinants...
